Marques A - Search Results

1

Expression of C-Reactive Protein and Serum Amyloid A in Early to Late Manifestations of Lyme Disease.

Uhde M, Ajamian M, Li X, Wormser GP, Marques A, Alaedini A. Uhde M, et al. Among authors: marques a. Clin Infect Dis. 2016 Dec 1;63(11):1399-1404. doi: 10.1093/cid/ciw599. Epub 2016 Sep 1. Clin Infect Dis. 2016. PMID: 27585799 Free PMC article.

2

Suppurative cutaneous granulomata caused by Microascus cinereus in a patient with chronic granulomatous disease.

Marques AR, Kwon-Chung KJ, Holland SM, Turner ML, Gallin JI. Marques AR, et al. Clin Infect Dis. 1995 Jan;20(1):110-4. doi: 10.1093/clinids/20.1.110. Clin Infect Dis. 1995. PMID: 7727636

3

Evaluation of a new culture medium for Borrelia burgdorferi.

Marques AR, Stock F, Gill V. Marques AR, et al. J Clin Microbiol. 2000 Nov;38(11):4239-41. doi: 10.1128/JCM.38.11.4239-4241.2000. J Clin Microbiol. 2000. PMID: 11060098 Free PMC article.

4

Lyme disease: an update.

Marques AR. Marques AR. Curr Allergy Asthma Rep. 2001 Nov;1(6):541-9. doi: 10.1007/s11882-001-0063-x. Curr Allergy Asthma Rep. 2001. PMID: 11892083 Review.

5

Evaluation of the C6 peptide enzyme-linked immunosorbent assay for individuals vaccinated with the recombinant OspA vaccine.

Marques AR, Martin DS, Philipp MT. Marques AR, et al. J Clin Microbiol. 2002 Jul;40(7):2591-3. doi: 10.1128/JCM.40.7.2591-2593.2002. J Clin Microbiol. 2002. PMID: 12089281 Free PMC article.

6

Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates.

Bacon RM, Biggerstaff BJ, Schriefer ME, Gilmore RD Jr, Philipp MT, Steere AC, Wormser GP, Marques AR, Johnson BJ. Bacon RM, et al. J Infect Dis. 2003 Apr 15;187(8):1187-99. doi: 10.1086/374395. Epub 2003 Apr 2. J Infect Dis. 2003. PMID: 12695997 Free PMC article.

7

Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis.

Fleming RV, Marques AR, Klempner MS, Schmid CH, Dally LG, Martin DS, Philipp MT. Fleming RV, et al. Among authors: marques ar. Eur J Clin Microbiol Infect Dis. 2004 Aug;23(8):615-8. doi: 10.1007/s10096-004-1163-z. Epub 2004 Jul 8. Eur J Clin Microbiol Infect Dis. 2004. PMID: 15243815 Clinical Trial.

8

Detection of immune complexes is not independent of detection of antibodies in Lyme disease patients and does not confirm active infection with Borrelia burgdorferi.

Marques AR, Hornung RL, Dally L, Philipp MT. Marques AR, et al. Clin Diagn Lab Immunol. 2005 Sep;12(9):1036-40. doi: 10.1128/CDLI.12.9.1036-1040.2005. Clin Diagn Lab Immunol. 2005. PMID: 16148168 Free PMC article.

9

A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis.

Philipp MT, Wormser GP, Marques AR, Bittker S, Martin DS, Nowakowski J, Dally LG. Philipp MT, et al. Clin Diagn Lab Immunol. 2005 Sep;12(9):1069-74. doi: 10.1128/CDLI.12.9.1069-1074.2005. Clin Diagn Lab Immunol. 2005. PMID: 16148173 Free PMC article.

10

Borrelia burgdorferi lipoprotein-mediated TLR2 stimulation causes the down-regulation of TLR5 in human monocytes.

Cabral ES, Gelderblom H, Hornung RL, Munson PJ, Martin R, Marques AR. Cabral ES, et al. J Infect Dis. 2006 Mar 15;193(6):849-59. doi: 10.1086/500467. Epub 2006 Feb 8. J Infect Dis. 2006. PMID: 16479520

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,688 results

Search Page